This paper is in the following e-collection/theme issue:

Reviews on Usage or other Formative Evaluation Metrics (53) Quality Improvement (282) Pharmacology and Pharmaceutics (91) E-Health / Health Services Research and New Models of Care (633)

Published on in Vol 5, No 3 (2021): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/14563, first published .
Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review

Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review

Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review

Authors of this article:

Samuel Bonet Olivencia1 Author Orcid Image ;   Farzan Sasangohar1, 2 Author Orcid Image
Article Authors Cited by (3) Tweetations (1) Metrics

Samuel Bonet Olivencia   1 * , BSc, MSc ;   Farzan Sasangohar   1, 2 * , BA, BCS, MASc, SM, PhD

1 Department of Industrial and Systems Engineering, Texas A&M University, College Station, TX, United States

2 Center for Outcomes Research, Houston Methodist Hospital, Houston, TX, United States

*all authors contributed equally

Corresponding Author:

  • Farzan Sasangohar, BA, BCS, MASc, SM, PhD
  • Department of Industrial and Systems Engineering
  • Texas A&M University
  • 3131 TAMU
  • College Station, TX 77843
  • United States
  • Phone: 1 9794582337
  • Email: sasangohar@tamu.edu